Susan R Rheingold

Summary

Affiliation: The Children's Hospital of Philadelphia
Country: USA

Publications

  1. ncbi request reprint Acute myeloid leukemia in a child with hereditary thrombocytopenia
    Susan R Rheingold
    Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Pediatr Blood Cancer 48:105-7. 2007
  2. doi request reprint Supportive care utilization and treatment toxicity in children with Down syndrome and acute lymphoid leukaemia at free-standing paediatric hospitals in the United States
    Elizabeth G Salazar
    Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
    Br J Haematol 174:591-9. 2016
  3. pmc Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemia
    Alix E Seif
    Division of Oncology, The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania
    Pediatr Blood Cancer 61:846-52. 2014
  4. pmc Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States
    Shannon L Maude
    1Division of Oncology, The Children s Hospital of Philadelphia, Philadelphia, PA 2Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 3Department of Anesthesia and Critical Care Medicine, The Children s Hospital of Philadelphia, Philadelphia, PA 4Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 5Division of Infectious Diseases, The Children s Hospital of Philadelphia, Philadelphia, PA 6Center for Pediatric Clinical Effectiveness, The Children s Hospital of Philadelphia, Philadelphia, PA 7Bristol Myers Squibb, Hopewell, NJ 8Division of Haematology Oncology and Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada 9Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 10Division of Pediatric Critical Care Medicine, Department of Pediatrics and Public Health Sciences, Penn State Hershey Milton S Hershey Medical Center, Hershey, PA
    Pediatr Crit Care Med 15:112-20. 2014
  5. pmc Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
    David T Teachey
    Division of Oncology, Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
    Blood 121:5154-7. 2013
  6. doi request reprint Intrathecal liposomal cytarabine in relapsed or refractory infant and pediatric leukemias: the Children's Hospital of Philadelphia experience and review of the literature
    Alix E Seif
    Division of Oncology, The Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
    J Pediatr Hematol Oncol 32:e349-52. 2010
  7. ncbi request reprint HIV infection presenting as severe autoimmune hemolytic anemia with disseminated intravascular coagulation in an infant
    Susan R Rheingold
    Divisions of Oncology, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Pediatr Hematol Oncol 26:9-12. 2004
  8. doi request reprint Secondary adrenal insufficiency in an infant after intrathecal triple chemotherapy
    Alix E Seif
    Division of Oncology, Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA
    Pediatr Blood Cancer 55:386-9. 2010
  9. doi request reprint Proactive enteral tube feeding in pediatric patients undergoing chemotherapy
    Nancy Sacks
    Department of Clinical Nutrition, Division of Oncology, Center for Childhood Cancer Research, The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania
    Pediatr Blood Cancer 61:281-5. 2014
  10. doi request reprint Complementary and alternative therapy use in pediatric oncology patients with failure of frontline chemotherapy
    Margot A Paisley
    The Children s Hospital of Philadelphia, Division of Oncology, Philadelphia, Pennsylvania, USA
    Pediatr Blood Cancer 56:1088-91. 2011

Collaborators

Detail Information

Publications20

  1. ncbi request reprint Acute myeloid leukemia in a child with hereditary thrombocytopenia
    Susan R Rheingold
    Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Pediatr Blood Cancer 48:105-7. 2007
    ..Despite his thrombocytopenia, the patient successfully completed intensive bone marrow cytoreduction without significant bleeding complications and is now in remission for over 3 years...
  2. doi request reprint Supportive care utilization and treatment toxicity in children with Down syndrome and acute lymphoid leukaemia at free-standing paediatric hospitals in the United States
    Elizabeth G Salazar
    Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
    Br J Haematol 174:591-9. 2016
    ..These findings highlight the importance of investigating the impact of these care variations and developing specific supportive care guidelines for this population. ..
  3. pmc Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemia
    Alix E Seif
    Division of Oncology, The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania
    Pediatr Blood Cancer 61:846-52. 2014
    ..We sought to ascertain patient- and hospital-level factors associated with induction mortality...
  4. pmc Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States
    Shannon L Maude
    1Division of Oncology, The Children s Hospital of Philadelphia, Philadelphia, PA 2Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 3Department of Anesthesia and Critical Care Medicine, The Children s Hospital of Philadelphia, Philadelphia, PA 4Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 5Division of Infectious Diseases, The Children s Hospital of Philadelphia, Philadelphia, PA 6Center for Pediatric Clinical Effectiveness, The Children s Hospital of Philadelphia, Philadelphia, PA 7Bristol Myers Squibb, Hopewell, NJ 8Division of Haematology Oncology and Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada 9Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 10Division of Pediatric Critical Care Medicine, Department of Pediatrics and Public Health Sciences, Penn State Hershey Milton S Hershey Medical Center, Hershey, PA
    Pediatr Crit Care Med 15:112-20. 2014
    ..Our objective was to determine hospital mortality of pediatric acute myeloid leukemia patients requiring intensive care...
  5. pmc Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
    David T Teachey
    Division of Oncology, Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
    Blood 121:5154-7. 2013
    ..This trial was registered at www.clinicaltrials.gov as #NCT00103285. ..
  6. doi request reprint Intrathecal liposomal cytarabine in relapsed or refractory infant and pediatric leukemias: the Children's Hospital of Philadelphia experience and review of the literature
    Alix E Seif
    Division of Oncology, The Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
    J Pediatr Hematol Oncol 32:e349-52. 2010
    ..Combined with other pediatric reports, our experience supports the efficacy of ITlipAC in pediatric and infant leukemic meningitis...
  7. ncbi request reprint HIV infection presenting as severe autoimmune hemolytic anemia with disseminated intravascular coagulation in an infant
    Susan R Rheingold
    Divisions of Oncology, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Pediatr Hematol Oncol 26:9-12. 2004
    ..The authors describe a 5-month-old infant who presented with severe autoimmune hemolytic anemia and disseminated intravascular coagulation as his initial manifestation of HIV infection...
  8. doi request reprint Secondary adrenal insufficiency in an infant after intrathecal triple chemotherapy
    Alix E Seif
    Division of Oncology, Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA
    Pediatr Blood Cancer 55:386-9. 2010
    ..As multiple pediatric leukemia protocols incorporate ITT, particularly in infants, we feel that ITT should be considered as a potential source of adrenal axis suppression...
  9. doi request reprint Proactive enteral tube feeding in pediatric patients undergoing chemotherapy
    Nancy Sacks
    Department of Clinical Nutrition, Division of Oncology, Center for Childhood Cancer Research, The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania
    Pediatr Blood Cancer 61:281-5. 2014
    ..To determine feasibility and safety of proactive enteral tube feeding (ETF) in pediatric oncology patients...
  10. doi request reprint Complementary and alternative therapy use in pediatric oncology patients with failure of frontline chemotherapy
    Margot A Paisley
    The Children s Hospital of Philadelphia, Division of Oncology, Philadelphia, Pennsylvania, USA
    Pediatr Blood Cancer 56:1088-91. 2011
    ..Secondary objectives included describing patient/family objectives for using CAM, satisfaction with CAM, financial and time expenditures on CAM, and patient desire for physician involvement in CAM use...
  11. doi request reprint Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
    David T Teachey
    Division of Oncology, The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania Department of Pediatrics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania Abramson Cancer Center, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
    Cancer Discov 6:664-79. 2016
    ..These comprehensive profiling data provide novel insights into CRS biology and, importantly, represent the first data that can accurately predict which patients have a high probability of becoming critically ill...
  12. pmc Zoonotic infections in pediatric patients with acute leukemia
    Katherine Lothstein
    Drexel University School of Public Health, Philadelphia, Pennsylvania
    Pediatr Blood Cancer 60:E160-2. 2013
    ..Gastrointestinal diseases were the most commonly (86.4%) identified zoonotic illnesses. Although rare, zoonotic diseases do occur in children with leukemia and frequency varies by age, region, and gender...
  13. doi request reprint Determining response and recurrence in pediatric B-cell lymphomas of the bone
    Alexandra J Borst
    Division of Pediatric Oncology, The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
    Pediatr Blood Cancer 60:1281-6. 2013
    ..A review of imaging in patients treated for primary bone lymphoma (PBL) in one center was performed in an effort to determine best practice...
  14. pmc Chimeric antigen receptor-modified T cells for acute lymphoid leukemia
    Stephan A Grupp
    Children s Hospital of Philadelphia, Philadelphia, PA 19104 4318, USA
    N Engl J Med 368:1509-18. 2013
    ..The emergence of tumor cells that no longer express the target indicates a need to target other molecules in addition to CD19 in some patients with ALL...
  15. doi request reprint Salvage therapy with nelarabine, etoposide, and cyclophosphamide in relapsed/refractory paediatric T-cell lymphoblastic leukaemia and lymphoma
    Leah A Commander
    Division of Oncology, The Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
    Br J Haematol 150:345-51. 2010
    ..Our experience supports the safety of giving AraG as salvage therapy in synchrony with etoposide and cyclophosphamide, although neurological toxicity must be closely monitored...
  16. ncbi request reprint Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment
    Deborah D Kennedy
    Division of Pediatric Oncology, Department of Pediatrics, College of Physicians and Surgeons of Columbia University, New York, New York, USA
    Pediatr Blood Cancer 44:378-85. 2005
    ..Children undergoing treatment for acute lymphoblastic leukemia (ALL) receive combination chemotherapy and many of the components are associated with free radical production...
  17. ncbi request reprint Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study
    Susan R Rheingold
    Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
    J Clin Oncol 25:1512-8. 2007
    ..To determine the maximum-tolerated dose, toxicity, pharmacokinetics, and biologic effects of G3139 when administered with doxorubicin and cyclophosphamide to children with relapsed solid tumors...
  18. doi request reprint Bone-marrow relapse in paediatric acute lymphoblastic leukaemia
    L Charles Bailey
    Division of Oncology, Children s Hospital of Philadelphia, and University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Lancet Oncol 9:873-83. 2008
    ..Although better drugs are needed, introduction of new agents into clinical trials in paediatric disease has been difficult. Innovative trial designs and use of valid surrogate endpoints may expedite this process...
  19. ncbi request reprint Role of the BCR complex in B cell development, activation, and leukemic transformation
    Susan R Rheingold
    Division of Oncology, Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
    Immunol Res 27:309-30. 2003
    ..This observation has lead directly to proposals to test drugs which may antagonize early B-cell growth signals, such as rapamycin, in acute lymphoid leukemia...
  20. ncbi request reprint A childhood cavernous conundrum
    Andrew G Lee
    Department of Ophthalmology, The University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242, USA
    Surv Ophthalmol 49:231-6. 2004
    ..He was treated with chemotherapy and made a dramatic recovery. Burkitt lymphoma rarely presents with a third nerve palsy but should be considered in the differential diagnosis of childhood cavernous sinus syndrome...